Skip to main content
Clinics and Practice logoLink to Clinics and Practice
. 2012 Jan 24;2(1):e16. doi: 10.4081/cp.2012.e16

Neuroendocrine carcinoma arising in a wound of the postoperative maxillary sinus

Takeshi Kusunoki 1, Katsuhisa Ikeda 1
PMCID: PMC3981353  PMID: 24765415

Abstract

We report a case of a neuroendocrine carcinoma arising in a wound of the postoperative maxillary sinus that was difficult to distinguish from a postoperative maxillary cyst. The patient was a 65-year-old Japanese woman who complained of left exophthalmos with cheek swelling and eye movement disorders. In past history, she had, 40 years previously undergone operation on the bilateral maxillary sinus by Caldwell-Luc's method. In a preoperative computed tomography, a mass occupied the left maxillary sinus showing irregular densities with destruction of the posterior bone walls and invasion into the left orbital. Both TI and T2 weighted magnetic resonance imaging showed low intensities and unevenness in the mass. We performed a biopsy of the maxillary tumor according to Caldwell-Luc's method. Histological examination diagnosed neuroendocrine carcinoma. Radiation therapy (total 66Gy) resulted in partial response for this tumor. However, sinonasal neuroendocrine carcinoma has been identified as highly aggressive, with a high probability of recurrence and metastasis.

Key words: neuroendocrine carcinoma, maxillary carcinoma, postoperative maxillary sinus, Radiation therapy, MRI.

Introduction

Maxillary carcinoma has seldom been known to arise in the postoperative maxillary sinus. Primary neuroendocrine carcinomas of the paranasal sinuses are newly recognized, extremely uncommon, and aggressive tumors with the capacity to metastasize locally and distantly.13 We encountered neuroendocrine carcinoma arising in the wound of a postoperative maxillary sinus. In preoperative diagnosis, it was difficult to discriminate between maxillary carcinoma and postoperative maxillary cyst. Biopsy of the maxillary mass revealed neuroendocrine carcinomas. After biopsy, tumors became partial remission in response to radiation therapy. This case suggests that the possibility of a carcinoma should be kept in mind in cases of postoperative maxillary sinus. Below we describe our case, as well as some of the considerations suggested by the literature on this topic.

Case Report

A 65-year-old Japanese woman consulted our hospital with a 1-week history of left exophthalmos with cheek swelling and eye movement disorders. Forty years prior, she had undergone an operation on the bilateral maxillary sinus by Caldwell-Luc's method. In a pre-operative computed tomography (CT) scan, a mass occupied the left maxillary sinus showing irregular densities with destruction of the posterior bone wall and invasion into the left orbital (Figures 1 and 2). Both TI and T2 weighted magnetic resonance imaging (MRI) showed low intensities and unevenness in the mass (Figure 3). Thus, CT and MRI suggested a solid mass in the maxillary. At the first medical examination, we suspected carcinoma arising in the postoperative maxillary sinus in addition to postoperative maxillary cyst. We performed biopsy of the maxillary tumor according to Caldwell-Luc's method. On the histological examination, the carcinoma tissues showed nesting patterns with necrosis, proliferation of cells with round nuclei and numerous abnormal mitotic features (Figure 4). Immunohistochemical studies showed positive staining for keratin, CAM5.2, and CD56, but not LCA (leukocyte common antigen). From the above results, we diagnosed neuroendocrine carcinoma. After biopsy, radiation therapy (total 66Gy) resulted in partial remission (PR) for this tumor. We consulted her concerning radio-chemotherapy or chemotherapy after radiation therapy for the remains of the tumors, but she refused the above combined chemotherapy. Regression of the tumor after therapy has been continued 24 months.

Figure 1.

Figure 1

In the preoperative computed tomography, a mass occupied the left maxillary sinus, showing irregular densities with destructions of the posterior bone wall (arrow).

Figure 2.

Figure 2

In the preoperative computed tomography, a mass occupied the left maxillary sinus, invading the orbita (arrow).

Figure 3.

Figure 3

T2 weighted magnetic resonance imaging showed low intensities with unevenness in the mass and destructions of the posterior bone wall (arrow).

Figure 4.

Figure 4

Histopathological examination (H&E staining, ×200) revealed nesting patterns with necrosis and the proliferation of cell round nuclei.

Discussion

Forty years previously, the patient had undergone an operation on the bilateral maxillary sinus by Caldwell-Luc's method. The majority of histopathological classifications of maxillary carcinomas are squamous cell carcinoma. Squamous cell carcinoma can be seldom observed in wounds of the postoperative maxillary sinus because removal of the maxillary mucosa membranes by Caldwell-Luc's method eliminates the place where squamous cell carcinoma arises. Silva2 and Mendeloff4 suggested olfactory epithelium as the original cell of neuroendocrine carcinoma, Schall5 reported spheno-palatine nerve. A main aggressive finding in this case showed destructions of the posterior bone wall in the maxillary sinus. Therefore, the origin of this neuroendocrine carcinoma may be spheno-palatine nerve. Neuroendocrine carcinoma consists of carcinoid and small cell carcinoma. It is difficult to be discriminate between carcinoid and small cell carcinoma. Moreover, the neuroendocrine carcinoma of nasal-parasinus has not been classified. Therefore, Tojima6 described it as small cell neuroendocrine carcinoma. In general, the cyst showed high intensities by T2weighted MRI.7 In this case, T2 weighted MRI showed low intensities with unevenness in the maxillary mass. Therefore, it was difficult to preoperatively distinguish carcinoma from a postoperative maxillary cyst. Finally, we diagnosed neuroendocrine carcinoma by biopsy. Silva et al.2 the first proposed sinonasal neuroendocrine carcinoma as an entity. In this case, destruction of the posterior bone wall and aggressive invasion into the orbital were found on CT. Smith et al.3 reported that sinonasal neuroendocrine carcinoma was a rare, and aggressive neoplasma.6,8,9 Our hematoxylin and eosin staining showed nesting patterns with the cells having round nuclei. These findings have been reported as one of features of the neuroendocrine carcinoma. It has been known that it is difficult to discriminate between the neuroendocrine carcinoma and olfactory neuroblastoma because the olfactory neuroblastomas as well as neuroendocrine carcinomas have filaments, microtubules, and secretory granules on electron microscopy.10 Immunohi stological examinations are helpful for the diagnosis. Our case showed positive staining for keratin, CAM5.2, and CD56. Their antibodies can be used to detect neuroepithelia. CAM 5.2, epithelia membrane antigen, neuron specific enclose, synatophysin, and chromogranin were reported to be reactive for neuroendocrine epithelia.1,3,9 Keratin is negative for olfactory neuroblastoma.11 Our patient was treated by radiation therapy alone. She has been alive 24 months after therapy with regression of the tumor. Presently, radiation therapy has been considered to be the first choice for the therapy of neuroendocrine carcinoma.12,13 Some cases have undergone chemoradiotherapy.6,13,14,15 Morikawa13 reported that a patient treated with chemo-radiotherapy was alive 21 months after diagnosis without local recurrence and distant metastasis. Reversely, Tojima6 documented that a patient received chemo-radiotherapy died from bone metastasis 7 month after diagnosis. Takahashi14 performed chemo-radiotherapy in 2 cases. But they died 6 months (bone metastasis) and 15 months (liver and brain metastasis) after diagnosis. Georgiou15 described that despite radiotherapy and chemotherapy; the patient died 4 months after diagnosis due to widespread dissemination and bone marrow failure. From the above reports, there has been no evidence of any difference in effectiveness between radiation therapy alone and chemo-radiotherapy. Bailey16 and Cartrell17 reported that only radiation therapy contributed to remission. Sinonasal neuroendocrine carcinoma is identified as highly aggressive, with a high probability of recurrence and metastasis. Takahashi et al.14 reported that the 5-year mortality of nasal-paranasal neuroendocrine carcinoma (30 cases) was 69%. Perez-Ordonez et al.1 reported that, out of 6 patients, 4 were alive with disease recurrence and 2 had died of the disease. Slivia et al.2 reported that recurrences and metastasis in 70% of the case occurred later than the third year. Multiple recurrences were present in 54% of the cases. The metastases affected lymph nodes, brain and spine. Therefore, careful follow -up after treatment of this disease is indicated.

Conclusions

We encountered a very rare case that a neuroendocrine carcinoma arising in a wound of the postoperative maxillary sinus was difficult to distinguish from a postoperative maxillary cyst. MRI and immunohistological examinations (e.g., Keratin, CAM5.2 and CD56) were helpful for diagnosis of this case. Radiation therapy has been considered the first choice for the therapy of neuroendocrine carcinoma. In our case, radiation therapy (total 66Gy) resulted in PR for this tumor. Regression of the tumor after therapy has been continued 24 months.

References

  • 1.Perez-Ordonez B, Caruana SM, Huvos AG, Shah JP. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. Hum Pathol. 1998;29:826–32. doi: 10.1016/s0046-8177(98)90452-x. [DOI] [PubMed] [Google Scholar]
  • 2.Silva EG, Butler JJ, Mackay B, Goepfert H. Neuroblastomas and neuroendocrine carcinomas of the nasal cavity: a proposed new classification. Cancer. 1982;50:2388–405. doi: 10.1002/1097-0142(19821201)50:11<2388::aid-cncr2820501126>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  • 3.Smith SR, Som P, Fahmy A, et al. A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma. Laryngoscope. 2000;110:1617–22. doi: 10.1097/00005537-200010000-00007. [DOI] [PubMed] [Google Scholar]
  • 4.Mendeloff J. The olfactory neuroepthelial tumors; a review of the literature and report of six additional cases. Cancer. 1957;10:944–56. doi: 10.1002/1097-0142(195709/10)10:5<944::aid-cncr2820100513>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  • 5.Schall LA, Lineback M. Primary intranasal neuroblastoma. Report of 3 cases. Ann Otol Rhinol Laryngol. 1951;60:221–9. doi: 10.1177/000348945106000118. [DOI] [PubMed] [Google Scholar]
  • 6.Tojima I, Suzuki M, Hanamitsu M, et al. Two cases of small cell neuroendocrine carcinoma in head and neck. Pract Otol (Kyoto) 2005;98:897–902. [Google Scholar]
  • 7.Som PM, Shapiro MD, Biller HF, et al. Sinonasal tumors and inflammatory tissues; differentiation with MR imaging. Radiology. 1888;167:803–8. doi: 10.1148/radiology.167.3.3363145. [DOI] [PubMed] [Google Scholar]
  • 8.Manome Y, Yamaoka R, Yuhki K, et al. [Intracranial invasion of neroendocine carcinoma: a case report] No Shinkei Geka. 1990;18:483–7. [Article in Japanese] [PubMed] [Google Scholar]
  • 9.Yanagi K, Kodama M, Hono H. Olfactory neuroblastoma and neuroendocrine carcinoma. ORL Tokyo. 1991;34:449–56. [Google Scholar]
  • 10.Contrucci RB, Holmes WF, Heffron T. Neuroendocrine tumors of the nose and upper airway. Ear Nose Throat J. 1985;64:235–8. [PubMed] [Google Scholar]
  • 11.Kodama A, Okabe H, Kitajima K, et al. Neuroendocrine carcinoma of the nasal cavity: a case report. Pract Otol (Kyoto) 1994;87:645–50. [Google Scholar]
  • 12.Gao W, Raeside DE. Orthovoltage radiation therapy treatment planning using Monte Carlo simulation: treatment of neuroendocrine carcinoma of the maxillary sinus. Phys Med Biol. 1997;42:2421–33. doi: 10.1088/0031-9155/42/12/009. [DOI] [PubMed] [Google Scholar]
  • 13.Morikawa T, Yoshihara T, Goto S, et al. Four cases of carcinoma in the nasal cavity which contained neurosecretory granules. Otologia Fukuoka. 2003;49:111–7. [Google Scholar]
  • 14.Takahashi N, Tsukuda M, Mochimatsu I, et al. [Neuroendocrine carcionoma of the head and neck] Nihon Jibiinkoka Gakkai Kaiho. 1996;99:567–75. doi: 10.3950/jibiinkoka.99.567. [Article in Japanese] [DOI] [PubMed] [Google Scholar]
  • 15.Georgiou AF, Walker DM, Collins AP, et al. Primary small cell undifferentiated (neuroendocine) carcinoma of the maxillary sinus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:572–8. doi: 10.1016/j.tripleo.2004.04.003. [DOI] [PubMed] [Google Scholar]
  • 16.Bailey BJ, Barton G. Olfactory neuroblastoma. Management and prognosis. Arch Otolaryngol. 1975;101:1–5. doi: 10.1001/archotol.1975.00780300005001. [DOI] [PubMed] [Google Scholar]
  • 17.Cantrell RW, Ghorayeb BY, Fitz-Hugh GS. Esthesioneuroblastoma: diagnosis and treatment. Ann Otol Rhinol Laryngol. 1977;86:760–5. doi: 10.1177/000348947708600608. [DOI] [PubMed] [Google Scholar]

Articles from Clinics and Practice are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES